Neural correlates of S-ketamine induced psychosis during overt continuous verbal fluency

NeuroImage

Volumn 54, Issue 2, 2011, Pages 1307-1314

  Nagels, Arne ^a   Kirner Veselinovic, André ^b   Krach, Sören ^a   Kircher, Tilo ^a  

^a PHILIPPS UNIVERSITY MARBURG   (Germany)

^b RWTH AACHEN UNIVERSITY   (Germany)

Author keywords

FMRI; Frontal cortex; Glutamate; Ketamine; N methyl d aspartate receptor; Schizophrenia

Indexed keywords

KETAMINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR;

ADULT; ARTICLE; BRAIN REGION; CONTROLLED STUDY; FRONTAL CORTEX; FUNCTIONAL MAGNETIC RESONANCE IMAGING; HUMAN; HUMAN EXPERIMENT; MALE; NORMAL HUMAN; PATHOPHYSIOLOGY; PHONETICS; POSITIVE AND NEGATIVE SYNDROME SCALE; PRIORITY JOURNAL; PSYCHOSIS; SCHIZOPHRENIA; SEMANTICS; TASK PERFORMANCE; TEMPORAL CORTEX; VERBAL BEHAVIOR;

ADULT; BRAIN; BRAIN MAPPING; DOUBLE-BLIND METHOD; EXCITATORY AMINO ACID ANTAGONISTS; HUMANS; IMAGE INTERPRETATION, COMPUTER-ASSISTED; KETAMINE; MAGNETIC RESONANCE IMAGING; PSYCHOTIC DISORDERS; SPEECH DISORDERS; VERBAL BEHAVIOR;

EID: 78649664703     PISSN: 10538119     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuroimage.2010.08.021     Document Type: Article

References (59)

1. Abel K.M., Allin M.P., Kucharska-Pietura K., Andrew C., Williams S., David A.S., Phillips M.L. Ketamine and fMRI BOLD signal: distinguishing between effects mediated by change in blood flow versus change in cognitive state. Hum. Brain Mapp. 2003, 18:135-145.
2. Abel K.M., Allin M.P., Kucharska-Pietura K., David A., Andrew C., Williams S., Brammer M.J., Phillips M.L. Ketamine alters neural processing of facial emotion recognition in healthy men: an fMRI study. NeuroReport 2003, 14:387-391.
3. Abi-Saab W.M., D'Souza D.C., Moghaddam B., Krystal J.H. The NMDA antagonist model for schizophrenia: promise and pitfalls. Pharmacopsychiatry 1998, 31(Suppl 2):104-109.
4. Adler C.M., Goldberg T.E., Malhotra A.K., Pickar D., Breier A. Effects of ketamine on thought disorder, working memory, and semantic memory in healthy volunteers. Biol. Psychiatry 1998, 43:811-816.
5. Allen G., McColl R., Barnard H., Ringe W.K., Fleckenstein J., Cullum C.M. Magnetic resonance imaging of cerebellar-prefrontal and cerebellar-parietal functional connectivity. Neuroimage 2005, 28:39-48.
6. Bokat C.E., Goldberg T.E. Letter and category fluency in schizophrenic patients: a meta-analysis. Schizophr. Res. 2003, 64:73-78.
7. Breier A., Malhotra A.K., Pinals D.A., Weisenfeld N.I., Pickar D. Association of ketamine-induced psychosis with focal activation of the prefrontal cortex in healthy volunteers. Am. J. Psychiatry 1997, 154:805-811.
8. Corlett P.R., Honey G.D., Aitken M.R., Dickinson A., Shanks D.R., Absalom A.R., Lee M., Pomarol-Clotet E., Murray G.K., McKenna P.J., Robbins T.W., Bullmore E.T., Fletcher P.C. Frontal responses during learning predict vulnerability to the psychotogenic effects of ketamine: linking cognition, brain activity, and psychosis. Arch. Gen. Psychiatry 2006, 63:611-621.
9. Crosson B., Benefield H., Cato M.A., Sadek J.R., Moore A.B., Wierenga C.E., Gopinath K., Soltysik D., Bauer R.M., Auerbach E.J., Gokcay D., Leonard C.M., Briggs R.W. Left and right basal ganglia and frontal activity during language generation: contributions to lexical, semantic, and phonological processes. J. Int. Neuropsychol. Soc. 2003, 9:1061-1077.
10. Curtis V.A., Bullmore E.T., Brammer M.J., Wright I.C., Williams S.C., Morris R.G., Sharma T.S., Murray R.M., McGuire P.K. Attenuated frontal activation during a verbal fluency task in patients with schizophrenia. Am. J. Psychiatry 1998, 155:1056-1063.
11. Curtis V.A., Bullmore E.T., Morris R.G., Brammer M.J., Williams S.C., Simmons A., Sharma T., Murray R.M., McGuire P.K. Attenuated frontal activation in schizophrenia may be task dependent. Schizophr. Res. 1999, 37:35-44.
12. Davies B.M., Beech H.R. The effect of 1-arylcylohexylamine (sernyl) on twelve normal volunteers. J. Ment. Sci. 1960, 106:912-924.
13. Deakin J.F., Lees J., McKie S., Hallak J.E., Williams S.R., Dursun S.M. Glutamate and the neural basis of the subjective effects of ketamine: a pharmaco-magnetic resonance imaging study. Arch. Gen. Psychiatry 2008, 65:154-164.
14. Frith C.D., Friston K.J., Herold S., Silbersweig D., Fletcher P., Cahill C., Dolan R.J., Frackowiak R.S., Liddle P.F. Regional brain activity in chronic schizophrenic patients during the performance of a verbal fluency task. Br. J. Psychiatry 1995, 167:343-349.
15. Fu C.H., Abel K.M., Allin M.P., Gasston D., Costafreda S.G., Suckling J., Williams S.C., McGuire P.K. Effects of ketamine on prefrontal and striatal regions in an overt verbal fluency task: a functional magnetic resonance imaging study. Psychopharmacology 2005, 183:92-102. (Berl).
16. Fu C.H., Suckling J., Williams S.C., Andrew C.M., Vythelingum G.N., McGuire P.K. Effects of psychotic state and task demand on prefrontal function in schizophrenia: an fMRI study of overt verbal fluency. Am. J. Psychiatry 2005, 162:485-494.
17. Ghoneim M.M., Hinrichs J.V., Mewaldt S.P., Petersen R.C. Ketamine: behavioral effects of subanesthetic doses. J. Clin. Psychopharmacol. 1985, 5:70-77.
18. Gunduz-Bruce H. The acute effects of NMDA antagonism: from the rodent to the human brain. Brain Res. Rev. 2009, 60:279-286.
19. Henry J.D., Crawford J.R. A meta-analytic review of verbal fluency deficits in schizophrenia relative to other neurocognitive deficits. Cogn. Neuropsychiatry 2005, 10:1-33.
20. Hetem L.A., Danion J.M., Diemunsch P., Brandt C. Effect of a subanesthetic dose of ketamine on memory and conscious awareness in healthy volunteers. Psychopharmacology 2000, 152:283-288. (Berl).
21. Holcomb H.H., Lahti A.C., Medoff D.R., Weiler M., Tamminga C.A. Sequential regional cerebral blood flow brain scans using PET with H2(15)O demonstrate ketamine actions in CNS dynamically. Neuropsychopharmacology 2001, 25:165-172.
22. Honey R.A., Honey G.D., O'Loughlin C., Sharar S.R., Kumaran D., Bullmore E.T., Menon D.K., Donovan T., Lupson V.C., Bisbrown-Chippendale R., Fletcher P.C. Acute ketamine administration alters the brain responses to executive demands in a verbal working memory task: an fMRI study. Neuropsychopharmacology 2004, 29:1203-1214.
23. Honey G.D., Honey R.A., O'Loughlin C., Sharar S.R., Kumaran D., Suckling J., Menon D.K., Sleator C., Bullmore E.T., Fletcher P.C. Ketamine disrupts frontal and hippocampal contribution to encoding and retrieval of episodic memory: an fMRI study. Cereb. Cortex 2005, 15:749-759.
24. Honey G.D., Corlett P.R., Absalom A.R., Lee M., Pomarol-Clotet E., Murray G.K., McKenna P.J., Bullmore E.T., Menon D.K., Fletcher P.C. Individual differences in psychotic effects of ketamine are predicted by brain function measured under placebo. J. Neurosci. 2008, 28:6295-6303.
25. Javitt D.C., Zukin S.R. Recent advances in the phencyclidine model of schizophrenia. Am. J. Psychiatry 1991, 148:1301-1308.
26. Kegeles L.S., Abi-Dargham A., Zea-Ponce Y., Rodenhiser-Hill J., Mann J.J., Van Heertum R.L., Cooper T.B., Carlsson A., Laruelle M. Modulation of amphetamine-induced striatal dopamine release by ketamine in humans: implications for schizophrenia. Biol. Psychiatry 2000, 48:627-640.
27. Kircher T.T., Rapp A., Grodd W., Buchkremer G., Weiskopf N., Lutzenberger W., Ackermann H., Mathiak K. Mismatch negativity responses in schizophrenia: a combined fMRI and whole-head MEG study. Am. J. Psychiatry 2004, 161:294-304.
28. Kircher, T., Nagels, A., Kirner-Veselinovic, A., Krach, S., subm. Rhymes in the brain: Neural correlates of phonological vs. semantic and lexical fluency.
29. Krach S., Hartje W. Comparison of hemispheric activation during mental word and rhyme generation using transcranial Doppler sonography. Brain Lang. 2006, 96:269-279.
30. Krystal J.H., Karper L.P., Seibyl J.P., Freeman G.K., Delaney R., Bremner J.D., Heninger G.R., Bowers M.B., Charney D.S. Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans. Psychotomimetic, perceptual, cognitive, and neuroendocrine responses. Arch. Gen. Psychiatry 1994, 51:199-214.
31. Krystal J.H., Karper L.P., Bennett A., D'Souza D.C., Abi-Dargham A., Morrissey K., Abi-Saab D., Bremner J.D., Bowers M.B., Suckow R.F., Stetson P., Heninger G.R., Charney D.S. Interactive effects of subanesthetic ketamine and subhypnotic lorazepam in humans. Psychopharmacology 1998, 135:213-229. (Berl).
32. Lahti A.C., Holcomb H.H., Medoff D.R., Tamminga C.A. Ketamine activates psychosis and alters limbic blood flow in schizophrenia. NeuroReport 1995, 6:869-872.
33. Lahti A.C., Koffel B., LaPorte D., Tamminga C.A. Subanesthetic doses of ketamine stimulate psychosis in schizophrenia. Neuropsychopharmacology 1995, 13:9-19.
34. Large C.H. Do NMDA receptor antagonist models of schizophrenia predict the clinical efficacy of antipsychotic drugs?. J. Psychopharmacol. 2007, 21:283-301.
35. Lezak M.D. Neuropsychological Assessment 1995, Oxford University Press. 3rd ed.
36. Luby E.D., Cohen B.D., Rosenbaum G., Gottlieb J.S., Kelley R. Study of a new schizophrenomimetic drug; sernyl. AMA Arch. Neurol. Psychiatry 1959, 81:363-369.
37. Malhotra A.K., Pinals D.A., Weingartner H., Sirocco K., Missar C.D., Pickar D., Breier A. NMDA receptor function and human cognition: the effects of ketamine in healthy volunteers. Neuropsychopharmacology 1996, 14:301-307.
38. Malhotra A.K., Pinals D.A., Adler C.M., Elman I., Clifton A., Pickar D., Breier A. Ketamine-induced exacerbation of psychotic symptoms and cognitive impairment in neuroleptic-free schizophrenics. Neuropsychopharmacology 1997, 17:141-150.
39. Moghaddam B., Adams B., Verma A., Daly D. Activation of glutamatergic neurotransmission by ketamine: a novel step in the pathway from NMDA receptor blockade to dopaminergic and cognitive disruptions associated with the prefrontal cortex. J. Neurosci. 1997, 17:2921-2927.
40. Murray J.B. Phencyclidine (PCP): a dangerous drug, but useful in schizophrenia research. J. Psychol. 2002, 136:319-327.
41. Newcomer J.W., Farber N.B., Jevtovic-Todorovic V., Selke G., Melson A.K., Hershey T., Craft S., Olney J.W. Ketamine-induced NMDA receptor hypofunction as a model of memory impairment and psychosis. Neuropsychopharmacology 1999, 20:106-118.
42. Northoff G., Richter A., Bermpohl F., Grimm S., Martin E., Marcar V.L., Wahl C., Hell D., Boeker H. NMDA hypofunction in the posterior cingulate as a model for schizophrenia: an exploratory ketamine administration study in fMRI. Schizophr. Res. 2005, 72:235-248.
43. Oldfield R.C. The assessment and analysis of handedness: the Edinburgh inventory. Neuropsychologia 1971, 9:97-113.
44. Olney J.W., Farber N.B. Glutamate receptor dysfunction and schizophrenia. Arch. Gen. Psychiatry 1995, 52:998-1007.
45. Olney J.W., Labruyere J., Price M.T. Pathological changes induced in cerebrocortical neurons by phencyclidine and related drugs. Science 1989, 244:1360-1362.
46. Ragland J.D., Moelter S.T., Bhati M.T., Valdez J.N., Kohler C.G., Siegel S.J., Gur R.C., Gur R.E. Effect of retrieval effort and switching demand on fMRI activation during semantic word generation in schizophrenia. Schizophr. Res. 2008, 99:312-323.
47. Rosenbaum G., Cohen B.D., Luby E.D., Gottlieb J.S., Yelen D. Comparison of sernyl with other drugs: simulation of schizophrenic performance with sernyl, LSD-25, and amobarbital (amytal) sodium; I. Attention, motor function, and proprioception. Arch. Gen. Psychiatry 1959, 1:651-656.
48. Schaufelberger M., Senhorini M.C., Barreiros M.A., Amaro E., Menezes P.R., Scazufca M., Castro C.C., Ayres A.M., Murray R.M., McGuire P.K., Busatto G.F. Frontal and anterior cingulate activation during overt verbal fluency in patients with first episode psychosis. Rev. Bras. Psiquiatr. 2005, 27:228-232.
49. Slotnick S.D., Schacter D.L. A sensory signature that distinguishes true from false memories. Nat. Neurosci. 2004, 7:664-672.
50. Slotnick S.D., Moo L.R., Segal J.B., Hart J. Distinct prefrontal cortex activity associated with item memory and source memory for visual shapes. Brain Res. Cogn. Brain Res. 2003, 17:75-82.
51. Szoke A., Trandafir A., Dupont M.E., Meary A., Schurhoff F., Leboyer M. Longitudinal studies of cognition in schizophrenia: meta-analysis. Br. J. Psychiatry 2008, 192:248-257.
52. Talairach J., Tournoux P. Co-planar stereotaxic atlas of the human brain 1988, Thieme Stuttgart, Germany.
53. Verma A., Moghaddam B. NMDA receptor antagonists impair prefrontal cortex function as assessed via spatial delayed alternation performance in rats: modulation by dopamine. J. Neurosci. 1996, 16:373-379.
54. Vogel A.P., Chenery H.J., Dart C.M., Doan B., Tan M., Copland D.A. Verbal fluency, semantics, context and symptom complexes in schizophrenia. J. Psycholinguist. Res. 2009.
55. Vollenweider F.X. Advances and pathophysiological models of hallucinogenic drug actions in humans: a preamble to schizophrenia research. Pharmacopsychiatry 1998, 31(Suppl 2):92-103.
56. Vollenweider F.X., Leenders K.L., Oye I., Hell D., Angst J. Differential psychopathology and patterns of cerebral glucose utilisation produced by (S)- and (R)-ketamine in healthy volunteers using positron emission tomography (PET). Eur. Neuropsychopharmacol. 1997, 7:25-38.
57. Vollenweider F.X., Leenders K.L., Scharfetter C., Antonini A., Maguire P., Missimer J., Angst J. Metabolic hyperfrontality and psychopathology in the ketamine model of psychosis using positron emission tomography (PET) and [18F]fluorodeoxyglucose (FDG). Eur. Neuropsychopharmacol. 1997, 7:9-24.
58. Vollenweider F.X., Vontobel P., Oye I., Hell D., Leenders K.L. Effects of (S)-ketamine on striatal dopamine: a [11C]raclopride PET study of a model psychosis in humans. J. Psychiatr. Res. 2000, 34:35-43.
59. Whitney C., Weis S., Krings T., Huber W., Grossman M., Kircher T. Task-dependent modulations of prefrontal and hippocampal activity during intrinsic word production. J. Cogn. Neurosci. 2009, 21:697-712.